Advertisement
Singapore markets closed
  • Straits Times Index

    3,332.80
    -10.55 (-0.32%)
     
  • Nikkei

    39,583.08
    +241.54 (+0.61%)
     
  • Hang Seng

    17,718.61
    +2.14 (+0.01%)
     
  • FTSE 100

    8,164.12
    -15.56 (-0.19%)
     
  • Bitcoin USD

    60,952.68
    +663.29 (+1.10%)
     
  • CMC Crypto 200

    1,266.46
    -17.37 (-1.35%)
     
  • S&P 500

    5,460.48
    -22.39 (-0.41%)
     
  • Dow

    39,118.86
    -45.20 (-0.12%)
     
  • Nasdaq

    17,732.60
    -126.08 (-0.71%)
     
  • Gold

    2,336.90
    +0.30 (+0.01%)
     
  • Crude Oil

    81.46
    -0.28 (-0.34%)
     
  • 10-Yr Bond

    4.3430
    +0.0550 (+1.28%)
     
  • FTSE Bursa Malaysia

    1,590.09
    +5.15 (+0.32%)
     
  • Jakarta Composite Index

    7,063.58
    +95.63 (+1.37%)
     
  • PSE Index

    6,411.91
    +21.33 (+0.33%)
     

Euronext Paris Growth Leaders With High Insider Stakes In June 2024

As the French market shows resilience with the CAC 40 Index climbing by 1.67%, investors are keenly observing trends and opportunities within this buoyant environment. In such a market, growth companies with high insider ownership can be particularly compelling, as this often signals confidence from those who know the company best.

Top 10 Growth Companies With High Insider Ownership In France

Name

Insider Ownership

Earnings Growth

VusionGroup (ENXTPA:VU)

13.5%

25.2%

Groupe OKwind Société anonyme (ENXTPA:ALOKW)

24.8%

30.8%

Adocia (ENXTPA:ADOC)

12.1%

104.5%

OSE Immunotherapeutics (ENXTPA:OSE)

25.6%

79.3%

Icape Holding (ENXTPA:ALICA)

30.2%

26.1%

Arcure (ENXTPA:ALCUR)

21.4%

42.4%

S.M.A.I.O (ENXTPA:ALSMA)

17.3%

35.2%

La Française de l'Energie (ENXTPA:FDE)

20.1%

34.2%

Munic (ENXTPA:ALMUN)

29.4%

150%

MedinCell (ENXTPA:MEDCL)

16.4%

74.6%

Click here to see the full list of 22 stocks from our Fast Growing Euronext Paris Companies With High Insider Ownership screener.

ADVERTISEMENT

We'll examine a selection from our screener results.

Lectra

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Lectra SA offers industrial intelligence solutions across the fashion, automotive, and furniture sectors in regions including Northern Europe, Southern Europe, the Americas, and Asia Pacific, with a market capitalization of approximately €1.06 billion.

Operations: The company generates revenue from the Americas and Asia Pacific regions, amounting to €170.33 million and €110.28 million respectively.

Insider Ownership: 19.6%

Lectra, a French growth company with high insider ownership, is currently trading 35.2% below its estimated fair value. Analyst consensus forecasts a promising 28.6% annual earnings growth over the next three years, outpacing the broader French market's 10.9%. Despite this robust profit outlook and competitive pricing relative to industry peers, revenue growth projections of 11.3% per year may not meet more aggressive market expectations of above 20%. Additionally, recent financial results show a slight decline in net income and earnings per share as of Q1 2024.

ENXTPA:LSS Ownership Breakdown as at Jun 2024
ENXTPA:LSS Ownership Breakdown as at Jun 2024

MedinCell

Simply Wall St Growth Rating: ★★★★★☆

Overview: MedinCell S.A. is a French pharmaceutical company that specializes in developing long-acting injectable medications across multiple therapeutic areas, with a market capitalization of approximately €389.41 million.

Operations: The company generates its revenue primarily from the pharmaceuticals segment, totaling €11.95 million.

Insider Ownership: 16.4%

MedinCell, a French biotech firm, is navigating through a challenging phase with recent financials showing a decrease in yearly revenue to €11.95 million and a net loss of €25.04 million, albeit an improvement from the previous year's larger losses. Despite setbacks in its Phase 3 trial for F14 not meeting primary pain reduction endpoints, there were promising signs in secondary measures such as knee mobility and swelling. The company is exploring regulatory pathways based on these outcomes. With high insider ownership, MedinCell's stock trades significantly below its fair value estimation and analysts anticipate substantial price growth. Revenue is expected to grow at 42.9% annually, outstripping the French market forecast of 5.8%.

ENXTPA:MEDCL Earnings and Revenue Growth as at Jun 2024
ENXTPA:MEDCL Earnings and Revenue Growth as at Jun 2024

OVH Groupe

Simply Wall St Growth Rating: ★★★★☆☆

Overview: OVH Groupe S.A. is a global provider of public and private cloud services, shared hosting, and dedicated server solutions, with a market capitalization of approximately €1.01 billion.

Operations: OVH Groupe's revenue is divided into three main segments: Public Cloud (€140.71 million), Private Cloud (€514.59 million), and Web Cloud (€179.45 million).

Insider Ownership: 10.5%

OVH Groupe, a French cloud services provider, is demonstrating robust growth with recent advancements in its product offerings. The introduction of ADV-Gen3 Bare Metal servers, leveraging AMD EPYC 4004 Series processors, marks a significant enhancement in performance and network capabilities. Financially, OVH reported a reduced net loss of €17.24 million for H1 2024 and an encouraging sales increase to €486.09 million from the previous year. Despite high volatility in its share price and low forecasted Return on Equity (3.7%), OVH's revenue growth is expected to outpace the French market significantly at 10.9% annually. The company's strategic focus on innovation and international expansion under new executive leadership further aligns with its growth trajectory while maintaining substantial insider ownership.

ENXTPA:OVH Earnings and Revenue Growth as at Jun 2024
ENXTPA:OVH Earnings and Revenue Growth as at Jun 2024

Summing It All Up

Ready To Venture Into Other Investment Styles?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include ENXTPA:LSSENXTPA:MEDCL ENXTPA:OVH and

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com